ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 926,36
1,65%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ImmunoGen Inc (IMGN)

  7. ImmunoGen Inc (IMGN) Actualités

IMGN ImmunoGen Inc

31,235
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
ImmunoGen Inc IMGN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 31,235 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
31,235 31,235
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/2/202422:15EDGAR2Form 15-12G - Securities registration termination [Section..
14/2/202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:33EDGAR2Form S-8 POS - Securities to be offered to employees in..
12/2/202415:32EDGAR2Form 25-NSE - Notification filed by national security..
12/2/202413:52EDGAR2Form 8-K - Current report
12/2/202413:37PRNUSAbbVie Completes Acquisition of ImmunoGen
08/2/202413:08EDGAR2Form 8-K - Current report
07/2/202413:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202403:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:10EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:09EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:08EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:07EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:30BWImmunoGen Announces Inducement Grants Under Nasdaq Listing..
31/1/202422:12EDGAR2Form 8-K - Current report
29/1/202423:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/1/202423:00EDGAR2Form 8-K - Current report
24/1/202422:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/1/202422:55EDGAR2Form 8-K - Current report
19/1/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202422:20EDGAR2Form 144 - Report of proposed sale of securities
12/1/202417:10PRNUSKuehn Law Encourages PXD, IMGN, HA and ICVX Investors to..

Dernières Valeurs Consultées

NASDAQ
IMGN
ImmunoGen
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés